Skip to content

A clinical trial on ayurvedic therapy in delayed and scanty menses

Role of jyotishmatyadi yoga and shatapushpa churna in the management of artava kshaya â?? A randomized control trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043068
Enrollment
30
Registered
2022-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

None listed

Sponsors

National Institute of AyurvedaJaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age of patient between 20-35 years, Married/unmarried patients suffering from any two of the following cardinal symptoms of ArtavaKshaya: 1-Yathochitakalaadarshanam -if the interval between 2 menstrual cycles exceeds more than 35 days. 2- Alpartavam â?? a) Duration of bleeding in PBAC (Pictorial blood loss assessment chart). b) Decrease in quantity of bleeding -score less than 20 in PBAC (Pictorial blood loss assessment chart). 3- YoniVedana - Pain during menstruation in internal genital organs.

Exclusion criteria

Exclusion criteria: 1-Pregnancy, labor or breastfeeding within the past 3 months. 2-History of intake of oral contraceptive or ovulation inducing agent within the past 3 months. 3- Established endocrine disorders. 4- Interval between 2 consecutive menstrual cycles is more than 6 months. 5- Oligomenorrhea with hypermenorrhea. 6- Patient suffering from any uterine or pelvic pathology. 7- Patient with any malignancy or anatomical defect. 8- Patient suffering from any severe systemic disorders. 9-Intake of psychoactive drugs or antiepileptic drugs (valproic acid).10- Patient vaccinated against covid19 within last3 months.

Design outcomes

Primary

MeasureTime frame
Changes in classical triad of ArtavaKshaya assessed on the basis of Pictorial blood loss assessment chart and Visual Analogue Scale (VAS).Timepoint: Base line, follow up in 15 days

Secondary

MeasureTime frame
1- Safety of drugs assessed through LFT and RFT. 2- Improvement in quality of lifeassessed through SF-36 questionnaire.Timepoint: 60 days

Countries

India

Contacts

Public ContactNikita Bhargava

NATIONAL INSTITUTE OF AYURVEDA

baruhunt@gmail.com9492047131

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026